We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Roche Diagnostics

Develops, manufactures, and markets a wide range of in vitro diagnostic systems, instruments, reagents, and tests read more Featured Products: More products

Download Mobile App




Digital Tumor Dashboard Improves Case Review Efficiency

By HospiMedica International staff writers
Posted on 19 Oct 2020
A new cloud-based tumor board (TB) integrates all relevant clinical data into a single digital dashboard accessible to everyone.

Developed by Roche (Basel, Switzerland) and GE Healthcare (GE, Little Chalfont, United Kingdom), the NAVIFY Tumor Board is designed to securely integrate and display relevant aggregated patient data, including information from electronic medical records (EMRs), lab results, radiology picture archiving and communication systems (PACS), and pathology reports. More...
All the data is integrated into a single, holistic dashboard for oncology care teams to review relevant patient data residing in disparate systems and inconsistent formats to help determine optimal treatment.

Key features and benefits include active directory (AD) Integration, allowing users to integrate their AD service with the NAVIFY Tumor Board, enabling seamless use of login credentials used throughout the health system; leveraging of the ICD-O-3 dictionary so that clinicians and oncologists can insert patient reviews and notes; and TB timeline event layout improvements, so that the order of the fields on the TB timeline events screen is more consistent with cancer info and patient history screens. On average, the Navify TB can reduce dashboard preparation time by 30%. The biggest time savings are on breast TB, where preparation time is reduced by 69%.

“This dashboard enables easy access to clinical data, which may support optimal decision-making. In addition, it reduces costs for both patients and hospitals. Institutions with dedicated nurses preparing for cases will likely benefit the most,” said Professor Richard Hammer, MD, of the University of Missouri School of Medicine (Columbia, USA). “NAVIFY Tumor Board helps physicians collect all of the data in one place so that we can make an informed decision, having all the different factors that might play into selecting the best treatment for the patient.”

Multidisciplinary TBs provide an interdisciplinary approach for decision-making in cancer care, and are integral to cancer treatment plans, bringing together clinicians from different specialties to guide patient treatment and improve outcomes. However, TB preparation is time and labor intensive, and requires a concerted effort from multiple hospital staff to compile clinically relevant data from a variety of sources and systems, often from different providers.



Gold Member
Real-Time Diagnostics Onscreen Viewer
GEMweb Live
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Business

view channel
Image: The collaboration will integrate Masimo’s innovations into Philips’ multi-parameter monitoring platforms (Photo courtesy of Royal Philips)

Philips and Masimo Partner to Advance Patient Monitoring Measurement Technologies

Royal Philips (Amsterdam, Netherlands) and Masimo (Irvine, California, USA) have renewed their multi-year strategic collaboration, combining Philips’ expertise in patient monitoring with Masimo’s noninvasive... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.